Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 first quarter ended December 31, 2024. The Company is hosting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback